Clinical Trial Update: Rituximab for the Treatment of Early Rheumatoid Arthritis (RA) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 evaluation of Rituximab for early rheumatoid arthritis; the trial was terminated and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-11-14